Skip navigation

Canlyniadau chwilio am the

Yn dangos 346 i 360 o 2036 canlyniadau

Consultation workshop: Standards of conduct, performance and ethics - sustainability

This workshop gives you an opportunity to ask questions about the revisions we have made

The standards of proficiency for arts therapists

The standards of proficiency that arts therapists must meet in order to join, and remain on, the HCPC Register. 

Assessing SET1 - Threshold level of qualification

This policy statement sets out our broad approach to assessing the threshold level of qualification for entry to the Register.

HCPC statement on guidance on health and character and suicidal ideation

Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.

Winners of the HCPC student competition 2023 announced

Find out who won the HCPC student competition 2023, which asked students to design a learning session about health and wellbeing. 

HCPC Corporate Plan 2025-26

The HCPC Corporate Plan 2025-26 sets out how we will continue to make progress on each of our six strategic priorities over the year.

Launch date announced for specialist social work regulator

Nadhim Zahawi has announced Monday 2 December 2019 as the date when Social Work England will take over from the HCPC as the new social work regulator

Launch of consultation for the standards of conduct, performance and ethics

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

The standards of proficiency for paramedics

The standards of proficiency that paramedics must meet in order to join, and remain on, the HCPC Register. 

Reclassification of Gabapentin and Pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

Top